Celldex Therapeutics Inc. (CLDX) Climbed 12.48% or 0.57 To Price $5.17 On Friday


Celldex Therapeutics Inc. (CLDX) climbed 12.48% or 0.57 to $5.17. It is about 569669 shares traded, which is 104.58% compare to the average total volume 544744. The market cap of CLDX is $62.61 million. The year to date change is 34.85%. The 52 week price range is from $2.75 to $42.9. Price of CLDX have changed -13.86% during last week. It have changed -21.75% over last month, 11.15% over last 3 months, -28.68% over last 6 months and -88.85% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 5.14. It is -0.58% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for CLDX is 6.34. It is 22.63% above current price. The 52-week High is 42.9. It is 729.79% from the current price. The 52-week Low is 2.75. It is -46.81% from current price.

There are some statistics of CLDX. It is has market cap $62.61 million. The share outstanding is 12.10 million. The average volume is 544744. The percent of top 15 Institution holding is 38.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -83.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -59.72%.


Tags:

Share this post